产品说明
Kitsize12x8MethodELISAIncubationtime1x1h,1x30min,1x15minStandardrange0.2-1680µg/lSpecimen/Volumes15µlSerum,PlasmaSubstrate/isotopeTMB,450nmRegulatoryStatus:EU:CEDetailsfor: IGFBP-2ELISAEnzymeImmunoassayforthequantitativeDeterminationofhumanInsulin-likeGrowthFactorBindingProtein-2(IGFBP-2)inhumanserum,EDTA-plasmacerebrospinalfluid,breastmilk,amnionticfluid,salivaandcellculturemedium.TheadvantagesofourIGFBP-2ELISAare:-measurementoftotalIGFBP-2concentrationinserum,plasmaandinotherhumanbodyfluids-singlestandardswith2,10,20,40and80ng/mL-totalIncubationtimeofonly1.75hours-2ControlsareprovidedforqualitycontrolpurposesaccordingGLP-ready-to-useAntibodyConjugate-nosampleextractionneeded-MicrotiterplateseperatelybreakapartCLINICALIMPLICATIONSTheIGFBP-2concentrationisage-dependentinblood.Normalvaluesforhealthyindividuals(1.5to>70years)wereevaluatedforthisassay.SupplementaryparametertoIGFBP-3inthediagnosisofgrowthdisorders(IGFBP-2/IGFBP-3ratio),IGFBP-2isaninhibitorofgrowthhormoneaction.Progression-dependenttumorMarkerinleukaemia,astrocysticCNStumors,prostate-,suprarenalcortex-,hepatocellularandothercarcinomas.IGFBP-2isalsoananti-agingparameter,asamarkerofphysiologicalfunctionality.Insulin-likegrowthfactors(IGFs)regulatetheproliferation,differentation,apoptose,celladhesionandmetabolisminvarioustissuesandcelltypes.TheIGF-I,whichisproducedmainlyinliverundertheinfluenceofgrowthhormone(GH),regulatesashormonethelineargrowthofthebonesandtheprocessofsexualmaturity,whileIGF-IIismainlyagrowthfactoroffetaltissue.TheBIOLOGicalactionsofIGFovertheIGF-Type-IreceptoraremodulatedvariablythroughtheIGFbindingproteins(IGFBP-1to-6).IGFBP-2is,afterIGFBP-3,thesecondmostfrequentIGFBPinthehumanblood.IGFs,especiallytumortypicalpro-IGF-formsandhormonesregulatetheexpressionofIGFBP-2,GHeffectistherebyinhibiting.AtcellularlevelIGFBP-2seemstostimulatetheproliferationanddisseminationofsolidtumorsviaanIGFindependentmechanism.PHYSIOLOGICALMEANINGIGFBP-2isaunglycosylatedpolypetideof31.3kDa,whichformsbinaryIGF-complexesandshowsnocircADIanrhythminthecirculation.TheserumconcentrationofIGFBP-2increasesinfasting,aftermajorsurgeryandaftertrauma,buttheincreasingoftheconcentrationismostintensiveinmalignantdiseases.ThecorrelationoftheIGFBP-2leveltothedegreeofprogressionisastrikingfeatureinvarioustumortypesasisthenormalizationoftheIGFBPserumlevelsafterremission.DuringtheGH-therapy,e.g.inshortstatureandinGHabuse(doping)theIGFBP-2leveldecreases.InTrisomy18IGFBP-2inmaternalserumisdecreasedandIGFBP-1isincreased;thereforetheratioIGFBP-2/IGFBP-1isamarkerforthischromosomeabnormality.ForconcretedatapleaseconsulttheInstructionforUseinthedownloadboxontherightside.
IBL我们的愿景是通过Tecan技术,产品和支持,为世界各地的每个实验室提供支持。
我们旨在通过无与伦比的专业知识,产品和客户支持来塑造生命科学和临床诊断自动化工作流程的未来。
新品排行榜
1
IBL/Anti-Osteopontin N-Half (34E...
2
IBL/IMMA/CM70275/
3
IBL/Anti-Human Gastrin Receptor ...
4
IBL/Anti-OPRT Rabbit IgG/JP28135...
5
IBL/15(S)-15-methyl Prostaglandi...
6
IBL/Annexin-V IgG/IgM ELISA/RE70...
7
IBL/CA 125 ELISA/RE54131/
8
IBL/ANA Screen 8 ELISA/RE75421/
9
IBL/ANA Profile 8 ELISA/RE75401/
10
IBL/MGP (modified gliadin peptid...
文章排行榜
1
Irinotecan | 97682-44-5
2
Lc laboratories
3
热烈庆祝上海迪奥生物代理瑞士Tecan公司系列产品
4
瑞士Tecan全新一代冷光源酶标仪 infinite F50 新品发布中
5
Tecan-Style Robotic Tip, Racked & Pre-Sterilized TT-20-C-HTR-S
6
TECAN F50酶标仪年底促销活动开始了!!
7
ASCO2013:利用循环肿瘤细胞可检测Etirinotecan pegol治疗转移性...
8
Tecan在Journal of Biomedical Optic的最新发表
9
TECAN
10
北京博宇腾辉科贸有限公司


